Powerful synergies exists in our model suggesting STAT pathway activation and mutation of Trp53 are potent drivers of B-ALL in the context of Etv6-RUNX1;Pax5+/−. This evidence concerns the gene SOAT1 and precursor B-cell acute lymphoblastic leukemia.